MA13.06 Amivantamab, Lazertinib Plus Platinum-based Chemotherapy in EGFR-mutated Advanced NSCLC: Updated Results from CHRYSALIS-2
Year: 2023
Type: conference-abstract
Source: Journal of Thoracic Oncology
Authors: S.-H. Lee, B.C. Cho, A.I. Spira, S.-H.I. Ou, S.N. Waqar, S. Shah, L. Trani, P.-L. Chu, M. Thayu, R.E. Knoblauch, J.M. Bauml, M.E. Marmarelis
Institutions: Samsung Medical Center, Sungkyunkwan University, Yonsei University, Yonsei University Health System, Yonsei Cancer Hospital, Virginia Cancer Specialists, University of California, Irvine, Washington University in St. Louis, Janssen Research & Development (United States), University of Pennsylvania
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4388084563